Intracavitary offline "in vivo" dosimetry for high dose-rate prostate brachytherapy with Ir-192: development of technology and first results of its application

«Radiation and Risk», 2017, vol. 26, No. 2, pp.72-82

DOI: 10.21870/0131-3878-2017-26-2-72-82


Stepanenko V.F. – Head of Lab., D. Sc., Biol., Prof. A. Tsyb MRRC. Contacts: 4 Korolev str., Obninsk, Kaluga region, Russia, 249036. Tel. (484) 399-70-02; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Biryukov V.A. – Senior Researcher, C. Sc., Med. A. Tsyb MRRC.
Kaprin A.D.1 – General Director of NMRRC, Academician of RAS, MD, Prof. NMRRC Ministry of Health of the Russian Federation.
Galkin V.N. – Director, MD, Prof. A. Tsyb MRRC.
Ivanov S.A. – Deputy Director, MD. A. Tsyb MRRC.
Karyakin O.B. – Head of Dep., MD, Prof. A. Tsyb MRRC.
Mardinskiy Yu.S. – Main Researcher, Corresponding Member of RAS, MD, Prof. A. Tsyb MRRC.
Gulidov I.A. – Head of Dep., MD, Prof. A. Tsyb MRRC.
Kolyzhenkov T.V. – Senior Researcher, C. Sc., Biol. A. Tsyb MRRC.
Ivannikov A.I. – Lead. Researcher, C. Sc., Phys.-Math. A. Tsyb MRRC.
Borisheva N.B. – Head of Dep., C. Sc., Phys.-Math. A. Tsyb MRRC.
Skvortsov V.G. – Head of Lab., C. Sc., Biol. A. Tsyb MRRC.
Akhmedova U.A. – Engineer;
Bogacheva V.V. – Engineer. A. Tsyb MRRC.
Petukhov A.D. – Research Assistant. A. Tsyb MRRC.
Yaskova E.K. – Lead. Researcher, C. Sc., Biol. A. Tsyb MRRC.
Khailov A.M. – Senior Researcher, C. Sc., Biol. A. Tsyb MRRC.
Lepilina O.G. – Med. Physicist. A. Tsyb MRRC.
Sanin D.B. – Med. Physicist, C. Sc., Biol. A. Tsyb MRRC.
Korotkov V.A. – Acting Head of Dep. A. Tsyb MRRC.
Obukhov A.A. – Physician Urologist, C. Sc., Med. A. Tsyb MRRC.
Anokhin Yu.N. – Senior Researcher, C. Sc., Med. A. Tsyb MRRC.


The first results of development and clinical testing the technology “in vivo” intracavitary dosimetry using offline mini- and microdetectors in the form of crystals of millimeter sizes and powders of microcrystals (Al2O3, alanine) in application to high dose rate brachytherapy of prostate cancer with 192Ir are presented in the paper. The detectors were hermetically packed inside flexible tissue-equivalent tubes in the conditions of electrons equilibrium, and then were placed inside the medical catheters. The measurements of radiation-induced signals in the detectors were conducted using two independent methods – by the method of thermally stimulated luminescence (TL) and by the method of electron paramagnetic resonance (EPR). Two different methods were used in order to be sure in the results of dose measurements. Absorbed doses were estimated using calibration dependencies constructed for each detector after irradiation of detectors by standard sources of ionizing radiation. This technology allow to measure of absorbed doses in many parts of the body and in a case of intracavitary locations of minidetectors, and in the absence of cable connections with registration systems. The testing of this technology was begun in A. Tsyb MRRC starting from 2016. The areas of interest for instrumental dose assessments defined by radiation oncologist are the following: bladder (catheter with microdosimeters was inserted through the urethra), and rectal area (catheter with microdosimeters was inserted through rectum). The usage of medical catheters is a part of high dose rate brachytherapy medical technology. Presence of detectors inside the catheter does not interfere with the carrying out of all necessary medical procedures – because of the miniature sizes of detectors. All procedures with inserting of microdetectors were carried out by a radiation oncologist under ultrasound control. Comparison of results of instrumental dosimetry and calculated data shows that in the region of the bladder the measured dose values agree quite well with calculated doses (the differences do not exceed 5% of calculated dose). Meanwhile, the calculated dose in the rectal region significantly exceeds the data obtained by instrumental method – from two to five times. It was concluded that existing system of therapeutic dose planning by calculation needs essential improvement in order to be more precise with accounting for real geometry of irradiated organs and tissues, as well as differences in densities of the irradiated tissues, especially between bone and soft tissues.

Key words
“in vivo” dosimetry, intracavitary instrumental dosimetry, brachytherapy, high dose-rate (high dose) brachytherapy, interstitial radiotherapy, 192Ir, prostate cancer, local absorbed doses, calculated doses, radiotherapy planning, radiation safety of patients, luminescent detectors, Al2O3, thermo-stimulated luminiscence, TL dosimetry, EPR spectroscopy, EPR dosimetry.


1. Kaprin A.D., Galkin V.N., Ivanov S.A. Rol' brahiterapii v lechenii lokalizovannyh form raka predstatel'noj zhelezy [The role of brachytherapy in the treatment of localized prostate cancer]. Biomedical Photonics, 2015, vol. 4, no. 4, pp. 21-26.

2. Ivanov S.A. Brahiterapija kak metod radikal'nogo lechenija pri rake predstatel'noj zhelezy. Diss. dokt. med. nauk [Brachytherapy as a method of radical treatment of prostate cancer. Dr. med. sci. diss.]. Moscow, 2011. 265 p.

3. Ivanov S.A., Kaprin A.D., Milenin K.N., Al'bickij I.A., Ivanenko K.V. Rezul'taty primenenija nizkodoznoj brahiterapii v kachestve radikal'nogo lechenija pri rake predstatel'noj zhelezy [Results of application of low-dose brachytherapy as a radical treatment of prostate cancer]. Diagnosticheskaja i intervencionnaja radiologija – Diagnostical and Interventional Radiology, 2015, vol. 5, no. 1, pp. 73-76.

4. Kaprin A.D., Pan'shin G.A., Al'bickij I.A., Milenin K.N., Cybul'skij A.D. Brahiterapija lokalizovannogo raka predstatel'noj zhelezy (medicinskaja tehnologija) [Brachytherapy of localized prostate cancer: medical technology]. Available at: (Accessed 8 January 2017).

5. WHO. Radiotherapy Risk Profile WHO/IER/PSP/2008.12. Geneva, WHO, 2008. 51 p. Available at: (Accessed 19 April 2017).

6. IAEA. Lessons learned from accidental exposures in radiotherapy. IAEA Safety Report Series 17. Vienna, IAEA, 2000. 96 p. Available at: (Accessed 19 April 2017).

7. IAEA. IAEA Human Health Reports No. 8 Development of Procedures for In Vivo Dosimetry in Radiotherapy. Vienna, IAEA, 2013. 178 p. Available at: pub1084_web.pdf (Accessed 19 April 2017).

8. Valentin J. Prevention of high-dose-rate brachytherapy accidents. ICRP Publication 97. Annals of the ICRP, 2005, vol. 35, no. 2, pp. 1-51.

9. Therriault-Proulx F., Briere T.M., Mourtada F., Aubin S., Beddar S., Beaulieu L. A phantom study of an in vivo dosimetry system using plastic scintillation detectors for real-time verification of 192Ir HDR brachytherapy. Med. Phys., 2011, vol. 38, no. 5, pp. 2542-2551. doi:10.1118/1.3572229.

10. Andersen C.E., Nielsen S.K., Greilich S., Helt-Hansen J., Lindegaard J.C., Tanderup K. Characterization of a fiber-coupled Al2O3:C luminescence dosimetry system for online in vivo dose verification during 192Ir brachytherapy. Med. Phys., 2009, vol. 36, no. 3, pp. 708-718. doi:10.1118/1.3063006.

11. Stepanenko V.F., Birjukov V.A, Karjakin O.B., Kaprin A.D., Galkin V.N., Ivanov S.A., Mardynskij Ju.S., Kolyzhenkov T.V., Petuhov A.D., Bogacheva V.V., Ahmedova U.A., Jas'kova E.K., Lepilina O.G., Sanin D.B., Skvortsov V.G., Ivannikov A.I., Hajlov A.M., Anohin Ju.N. Local absorbed doses of irradiation of medical personnel at brachytherapy of prostate cancer using 125I microsources of Russian production. Radiatsiya i risk – Radiation and Risk, 2017, vol. 26, no. 1, pp. 44-59. (In Russian).

12. Briemeister J.F. MCNP – A general Monte-Carlo N-particle transport code. Version 4C. Los Alamos, Los Alamos National Laboratory, 2000.

13. Adult Reference Computational Phantoms: ICRP Publication 110. Annals of the ICRP, 2009, vol. 39, no. 2, pp. 1-165.

14. Agyingi E.O., Mobit P.N., Sandison G.A. Energy response of an aluminum oxide detector in kilovoltage and megavoltage photon beams: An EGSnrc Monte-Carlo simulation study. Radiat. Prot. Dosim., 2005, vol. 118, pp. 28-31.

15. Asni H.B. Photon energy response of silicon dioxide fibre optic and TLD 100 using Monte-Carlo simulation. Universiti Teknologi Malaysia, 2011. 72 p. Available at: HazilaAsniMFS2011.pdf (Accessed 19 April 2017).

Full-text article (in Russian)